| Name | Title | Contact Details |
|---|---|---|
Scott Sargent |
Director of Sales | Profile |
Eric Lader |
VP R&D NGS Technologies | Profile |
Dominic John |
VP of Marketing and Clinical Product Management | Profile |
Jonathan Shaffer |
Director, Research & Development | Profile |
Leah Ackerson |
Associate Director, Marketing - Immune Responses North America | Profile |
Caprion Proteomics Inc. is a Gatineau, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Genpathway, Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Bioinformatics.org is a Framingham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1).
Right from the beginning, which is now more than fifty years ago, Bruker has been driven by a single idea: to provide the best technological solution for each analytical task` Today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge` Bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability` Bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers` As one of the world's leading analytical instrumentation companies, Bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions` Bruker - Innovation with Integrity`